Orthofix Medical Inc. - Common Stock (NQ:OFIX)

9.090 -0.120 (-1.30%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Orthofix Medical Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Earnings Scheduled For February 25, 2022 ↗

February 25, 2022

Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...

Via Benzinga

Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures

February 22, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25, 2022

February 10, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems

January 19, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results

January 10, 2022

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Appointment of Thomas A. West to Board of Directors

December 14, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical's Return on Invested Capital Overview ↗

November 08, 2021

Benzinga Pro data, Orthofix Medical (NASDAQ:OFIX) reported Q3 sales of $112.43 million. Earnings fell to a loss of $313.00 thousand, resulting in a 107.34% decrease from last...

Via Benzinga

Orthofix Medical inc (OFIX) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

OFIX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill ↗

November 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...

Via Benzinga

Orthofix Reports Third Quarter 2021 Results

November 05, 2021

From Orthofix Medical Inc.

Via Business Wire

Earnings Scheduled For November 5, 2021 ↗

November 05, 2021

Companies Reporting Before The Bell • Brookfield Renewable (NYSE:BEPC) is projected to report earnings for its third quarter. • Healthcare Trust (NYSE:HTA) is...

Via Benzinga

Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences

November 03, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 5, 2021

October 27, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Provides Business Update

September 29, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted Worldwide

September 27, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Appointment of Wayne Burris to Board of Directors

September 23, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures

September 21, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference

September 20, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical's Return on Invested Capital Insights ↗

September 09, 2021

According to Benzinga Pro, during Q2, Orthofix Medical (NASDAQ:OFIX) earned $4.27 million, a 246.33% increase from the preceding quarter. Orthofix Medical also posted a total of $...

Via Benzinga

Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System

September 01, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Medical inc (OFIX) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

OFIX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook ↗

August 06, 2021

Orthofix Medical Inc (NASDAQ: OFIX) reported Q2 adjusted EPS $0.32, compared to an adjusted net loss of $(0.59) a year ago, beating the consensus of $0.11. Sales...

Via Benzinga

Orthofix Medical: Q2 Earnings Insights ↗

August 06, 2021

Shares of Orthofix Medical (NASDAQ:OFIX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 154.24% over the past year to...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Orthofix Reports Second Quarter 2021 Results

August 06, 2021

From Orthofix Medical Inc.

Via Business Wire

Earnings Scheduled For August 6, 2021 ↗

August 06, 2021

Companies Reporting Before The Bell • Liberty Braves Group (NASDAQ:BATRA) is projected to report quarterly loss at $0.03 per share on revenue of $154.00 million....

Via Benzinga

Orthofix Announces First Patient Implant in the M6-C Artificial Cervical Disc Two-Level IDE Study

August 02, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021

July 28, 2021

From Orthofix Medical Inc.

Via Business Wire

Orthofix Announces US Launch and First Patient Implants with New fiberFUSE Strip – An Advanced Fiber Bone-Graft Solution Containing Cancellous Bone

July 28, 2021

From Orthofix Medical Inc.

Via Business Wire

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.